Ampicillin/Sulbactam Vs. Cefoxitin for the Treatment of Pelvic Inflammatory Disease

Objective: The safety and efficacy of ampicillin plus sulbactam were compared with those of cefoxitin in the treatment of women with pelvic inflammatory disease (PID). Methods: This single-site, randomized, prospective, third-party-blinded, comparative, parallel-treatment study enrolled 93 women wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Jemsek, Joseph G., Harrison, Frank
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364580/
https://www.ncbi.nlm.nih.gov/pubmed/18476179
http://dx.doi.org/10.1155/S1064744997000562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364580/
https://www.ncbi.nlm.nih.gov/pubmed/18476179
http://dx.doi.org/10.1155/S1064744997000562

Ejemplares similares